AMVUTTRA Trademark

Trademark Overview

On Tuesday, September 1, 2020, a trademark application was filed for AMVUTTRA with the United States Patent and Trademark Office. The USPTO has given the AMVUTTRA trademark a serial number of 90151672. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The AMVUTTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of amyloidosis
amvuttra

General Information

Serial Number90151672
Word MarkAMVUTTRA
Filing DateTuesday, September 1, 2020
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6840129
Registration DateTuesday, September 6, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of amyloidosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 7, 2020
Primary Code005
First Use Anywhere DateFriday, July 1, 2022
First Use In Commerce DateTuesday, July 5, 2022

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, September 4, 2020NEW APPLICATION ENTERED
Wednesday, October 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Wednesday, December 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 16, 2021SOU EXTENSION 1 FILED
Thursday, September 16, 2021SOU EXTENSION 1 GRANTED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 18, 2022SOU EXTENSION 2 FILED
Friday, February 18, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022SOU EXTENSION 2 GRANTED
Tuesday, February 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 15, 2022TEAS STATEMENT OF USE RECEIVED
Friday, July 15, 2022USE AMENDMENT FILED
Friday, July 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 3, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

amvuttra amyloidosis treatment preparations pharmaceutical